Global Preclinical Isolated Organ Perfusion System Market to Surpass US$ 589.1 Million by 2027, Says Coherent Market Insights (CMI) | Financial Buzz

Global Preclinical Isolated Organ Perfusion System Market to Surpass US$ 589.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global preclinical isolated organ perfusion system market is estimated to be valued at US$ 442.8 million in 2020 and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Preclinical Isolated Organ Perfusion System Market:

Key trends in the market are the rising incidence of organ transplants, increasing incidence of chronic diseases such as cardiovascular diseases, kidney diseases and others, and research and development of perfusion systems.

Market players and research organizations are focusing on development of novel perfusion systems which is expected to drive the market growth. According to an article titled- The future of organ-oriented research and treatment published by the Hepatobiliary Surgery and Nutrition (HSBN), in August 2019, research results using machine perfusion in solid organ transplantation had raised the interest in the organ transplantation and combining these technologies in surgery, oncology, pharmacology, immunology, metabolomics, gene and (stem) cell therapy has great potential and opportunity to establish an organ level research and treatment platform for human medicine and diseases.

Similarly, surging demand for organ transplantation in the region is expected to boost growth of the market in this region during the forecast period. According to an article published by the National Health Service (NHS) Blood and Transplant, an executive non-departmental public body in the U.K, reports that around 3,763 organ transplants through deceased donors have been performed and around 4,670 people are waiting for a transplant in the U.K. during April 2019 to March 2020.

Buy-Now this Research Report for detailed Insights @

https://www.coherentmarketinsights.com/insight/buy-now/4351

Key Market Takeaways:

The global preclinical isolated organ perfusion system market is expected to exhibit a CAGR of 4.2% during the forecast period owing to an increasing number of organ transplants. According to an article published by the U.S. Department of Health and Human Services, in 2017, 34,770 organ transplants were performed in the U.S.

Increasing number of authorized hospitals to perform organ transplants is expected to drive growth of the market in this region during the forecast period. According to an article the LWW Journal, in October 2016, around 362 hospitals were authorized to perform organ transplants in Mexico in 2016.

Competitive Landscape:

Key players operating in the global preclinical isolated organ perfusion system market are World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. among others.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4351

Market Segmentation:

  • Global Preclinical Isolated Organ Perfusion System Market, By Type:

    • Isolated Heart Perfusion Systems
    • Isolated Abdominal Organ Perfusion Systems
    • Isolated Lung Perfusion Systems
    • Others
  • Global Preclinical Isolated Organ Perfusion System Market, By End User:

    • Industrial Laboratories and CROs
    • Academic and Government Research Institutes
  • Global Preclinical Isolated Organ Perfusion System Market, By Region:

    • North America

      • By Country:

        • U.S.
        • Canada
    • Latin America

      • By Country:

        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe

      • By Country:

        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific

      • By Country:

        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • By Country:

        • GCC
        • Israel
        • Rest of Middle East
    • Africa

      • By Country/Region:

        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Perfusion System Market, by Product Type (Cardiopulmonary Perfusion Systems, Ex Vivo Organ Perfusion Systems, and Cell Perfusion Systems), by Component (Heart-Lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas, and Others), by End User (Hospitals, Ambulatory Care Centers, and Others), and by Region – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Read more: https://www.coherentmarketinsights.com/ongoing-insight/perfusion-system-market-1661

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:

US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Follow Us: LinkedIn | Twitter